摘要 |
This invention refers to medicine, in particular to pharmacology and pharmacotherapy. The technical result is to prevent specific expiratory bronchospasm in patients with bronchial asthma and other diseases and pathological conditions. The principally new indication provides use of antiepileptic agents for treatment of all types of bronchial asthma, status asthmaticus, asthmatic and allergic bronchitis, bronchial hyperreactivity and bronchospastic syndromes and treatment of diseases proceeding with these syndromes and also for treatment of allergic and vasomotor rhinitis and rhinoconjunctivitis. |